| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| GIPR | Biotinylated Human GIPR Protein, His,Avitag™ (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $450.00 25ug | |||
| GIPR | Cynomolgus GIPR Protein, His Tag | Cynomolgus | HEK293 | ![]() | SDS-PAGE | $385.00 100ug | |||
| GIPR | AvitagAIDD‑Ready GIR-C82E3 | Biotinylated Cynomolgus GIPR Protein, His,Avitag™ | Cynomolgus | HEK293 | ![]() | SDS-PAGE | $415.00 25ug | ||
| GIPR | Human GIPR Protein, Fc Tag, low endotoxin (MALS & SPR verified) | Human | HEK293 | ![]() | SDS-PAGE | $500.00 100ug | |||
| GIPR | Human GIPR Protein, His,Flag Tag (Detergent) | Human | HEK293 | ![]() | $805.00 20ug | ||||
| GIPR | Human GIPR Protein, His Tag (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $500.00 100ug | |||
| GIPR | Human GIPR Protein (VLP) | Human | HEK293 | $620.00 20ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| AT-02 | AT-02 | Phase 2 Clinical | Attralus Inc | Immunoglobulin Light-chain Amyloidosis; Amyloidosis | Details |
| Anti-CD33/anti-FcgammaRI bispecific antibody (UCSD) | Phase 1 Clinical | University Of California San Diego | Leukemia, Myeloid, Acute | Details |
| English Name | Research Code | Highest Development Stage | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Imlifidase | Mac-1 | Approved | Hansamed Inc | Idefirix | EU | Rejection of renal transplantation | Hansa Biopharma Ab | 2020-08-25 | Rejection of renal transplantation; Kidney Diseases; Purpura, Thrombotic Thrombocytopenic; Rejection of organ transplantation; Renal Insufficiency, Chronic; Guillain-Barre Syndrome; Kidney Failure, Chronic | Details |